PKM and urinary bladder cancer: m5C RNA modification promotes the pathogenesis of bladder cancer by stabilizing mRNAs, and ALYREF stabilizes PKM2 mRNA by binding m5C sites in the 3′UTR in bladder cancer (Wang et al, 2021; Wang et al, 2023).